Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 2

Effi cacy of Intravitreal Afl ibercept for Macular Edema Secondary to Retinal Macroaneurysm “A story from RAM to RAP”

Retinal Makroanevrizmaya Bağlı Makula Ödeminde İntravitreal Afl ibercept’in Etkinliği “RAM’den RAP’a bir öykü”

Pages
162–169
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to our best of knowledge, our article is the second report conducting the use of intravitreal afl ibercept for the treatment of RAM in the literature..

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We presented a case with decreased vision due to macular edema secondary to retinal macroaneurysm (RAM) which was treated with intravitreal afl ibercept.
📊
Key Findings & Data:The patient was treated with 3 consecutive monthly injections of intravitreal afl ibercept.
💡
Conclusion & Impact:According to our best of knowledge, our article is the second report conducting the use of intravitreal afl ibercept for the treatment of RAM in the literature..
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We presented a case with decreased vision due to macular edema secondary to retinal macroaneurysm (RAM) which was treated with intravitreal afl ibercept. Seventy-six-year-old male patient which was under follow-up for age-related macular degeneration in the reti- na department presented with retinal edema covering all macular area due to a macroaneurysm in the superior temporal branch of the retinal artery. The patient was treated with 3 consecutive monthly injections of intravitreal afl ibercept. Macular edema was observed to gradually decreased with complete closure of the RAM after the treatment. The best corrected visual acuity improved from 3/10 at baseline to 7/10 after the treatment. Ocular or systemic side effect was not observed. Intravitreal afl ibercept can provide closure of RAM, disappearance of macular edema by gradual resolution and hence improvement of visual acuity. Intravitreal afl ibercept can be considered as an alternative and effective way of the treatment in cases with decreased visual acuity due to macular edema secondary to RAM. According to our best of knowledge, our article is the second report conducting the use of intravitreal afl ibercept for the treatment of RAM in the literature..

Özet

Retinal makroanevrizmaya (RAM) sekonder maküla ödemi nedeni ile görme kaybı şikâyeti ile başvuran olguda yaptığımız intravitreal afl iberceptin etkisini ortaya koymak amacı ile bu olgunun sunulması amaçlanmıştır. Yaşa bağlı maküla dejenerasyonu nedeni ile retina biriminde takip edilen 76 yaşındaki erkek hastanın kontrol muayenesinde üst temporal arter de makroanevrizma ve makulayı da içine alan retina ödem saptandı. Hastaya 3 doz intravitreal afl ibercept tedavisi uygulandı. Tedavi sonrası ödemin kaybolduğu ve RAM’ın tamamen kapanmış olduğu izlendi. En iyi düzeltilmiş görme keskinliği 3/10 ‘dan 3 doz intravitreal afl ibercept enjeksiyonu sonrası 7/10 ‘a yükseldi. Oküler veya sistemik yan etki saptanmadı. İntravitreal afl ibercept tedavisi, RAM’ın kapanmasına, gelişmiş olan ödemin gerileyerek kaybolmasına ve dolayısı ile görme artışına neden olabilir. İntravitreal afl ibercept RAM’a bağlı maküla ödemi nedeniyle görme azlığı gelişen olgularda alternatif ve etkin bir tedavi yöntemi olabilir. Makalemiz, literatürde bulabildiğimiz kadarıyla RAM tedavisinde intravitreal afl ibercept kullanımını bildiren ikinci rapordur.

🔖

Cite This Article

ERTAN, E., İNAN, S., İNAN, Ü. Ü. (2018). Effi cacy of Intravitreal Afl ibercept for Macular Edema Secondary to Retinal Macroaneurysm “A story from RAM to RAP”. Retina-Vitreus, Cilt: 27 - Sayı: 2, 162–169. https://ajindex.com/articles/304827

References (12)

  1. Rabb MF, Gagliano DA, Tesk MP. Retinal arterial macroaneu- rysms. Surv Ophthalmol 1988;33:73-96.
  2. Panteon RW, Goldberg MF, Farber MD. Retinal arterial mac- roaneurysms: risk factors and natural history. Br J Ophthalmol 1990;74:595-600.
  3. Chew EY, Murphy PR. Acquired retinal macroaneurysms. In Ryan SJ, ed: Retina, St Louis, Mosby 2001;86:1500-4.
  4. Takahashi K, Kishi S. Serous macular detachment associated with retinal arterial macroaneurysm. Jpn J Ophthalmol 2006;50:460-4.
  5. Cleary PE, Kohner EM, Hamilton AM, Bird AC. Retinal macroan- eurysms. Br J Ophthalmol 1975;59:355-361.
  6. Ohno-Matsui K, Hayano M, Futagami S, Tokoro T, Ohno S. Spon- taneous involution of a large retinal arterial macroaneurysm. Acta Ophthalmol Scand.2000;78:114-7.
  7. Brown DM, Sobol WM, Folk JC, Weingeist TA. Retinal arterio- lar macroaneurysms: long-term visual outcome. Br J Ophthalmol. 1994;78:534–538
  8. Koinzer S, Heckmann J, Tode J, Roider J: Long-term, thera- py-related visual outcome of 49 cases with retinal arterial mac- roaneurysm: a case series and literature review. Br J Ophthalmol 2015;99:1345– 1353. Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of Anti-Vascular Endothelial Growth Fac- tor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthalmology. 2016 Nov 24.pii: S0161- 6420(16)31834-6.
  9. Chanana B, Azad RV. Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye (Lond) 2009;23:493- 494. Golan S, Goldenberg D, Goldstein M. Long-term follow-up of in- travitreal bevacizumab in retinal arterial macroaneurysm: a case report. Case Report Ophthalmol 2011;2:387-391.
  10. Cho HJ, Rhee TK, Kim HS, Han JI, Lee DW, Cho SW, Kim JW. Intravitreal bevacizumab for symptomatic retinal arterial mac- roaneurysm. Am J Ophthalmol. 2013;155:898-904
  11. Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella AP, Nucci P. Intravitreal bevaci- zumab for macular complications from retinal arterial macroaneu- rysms. Am J Ophthalmol. 2013;155:287-294.
  12. Wenkstern AR, Petersen H. Intravitreal ranibizumab in retinal mac- roaneurysm. Graefes Arch Clin Exp Ophthalmol 2010;248:1667- 1670. Kishore K. Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Afl ibercept Injection. Case Rep Ophthalmol. 2016;7:162-171.